Loading organizations...
Pharmascience develops and manufactures a broad portfolio of generic, branded, and over-the-counter pharmaceuticals for global markets. The company emphasizes pharmaceutical innovation, employing continuous research and development to deliver effective, accessible treatments. Its approach ensures a wide offering across diverse therapeutic areas, meeting varied medical needs.
Pharmacists Morris Goodman and Ted Wise founded the company in 1983. Their initial insight stemmed from recognizing a critical need for accessible and reliable pharmaceutical products, leading to its establishment in Montreal, Quebec. This foundational understanding of patient requirements has since guided its strategic direction and development.
Pharmascience serves patients and healthcare providers worldwide, supplying essential and affordable medications. The company's vision is to enhance global health and well-being by providing trusted pharmaceutical solutions. It aims to support its customers and communities, fostering better health outcomes and making a significant impact on public health.
Pharmascience has 1 tracked investment across 1 company. The latest tracked deal is $9.5M Series B in RDD Pharma in November 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 16, 2017 | RDD Pharma | $9.5M Series B | — | Capital Point, OrbiMed |